We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Sangamo and Pfizer together developed the treatment, called giroctocogene fitelparvovec, and it was licensed to Pfizer. The collaboration and license agreement will terminate on April 21, and Pfizer ...

Pfizer Inc. closed $5.12 below its 52-week high ($31.54), which the company reached on July 30th.

A judge who is married to a former Pfizer executive is overseeing Mangione’s federal pretrial hearings. But she won’t oversee ...

"Federal law requires defendants to ensure that their drug labels remain accurate, and when new scientific information ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Research commissioned by the United Kingdom's government shows that smoking is even more harmful than previously thought. For ...

Ibrance is under clinical development by Pfizer and currently in Phase III for Metastatic Breast Cancer. According to GlobalData, Phase III drugs for Metastatic Breast Cancer have a 44% phase ...

The Biogen Inc. story of the last 10 years has been one of periods of excitement, followed by significant disappointments.

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.